Barriers to breast cancer screening for people with disabilities

Bull Cancer. 2021 Oct 14:S0007-4551(21)00368-4. doi: 10.1016/j.bulcan.2021.07.009. Online ahead of print.ABSTRACTA significant increase in breast cancer is expected in the coming decades among people with disabilities. However, their participation rate in screening programs is significantly lower than women without disabilities. Our objective was therefore to analyse the barriers to breast cancer screening in people with disabilities based on a recent review of the international literature. The articles analysed were retrieved from the PUBMED database from 2014 to 2020 using the following keywords "breast cancer", "screening" and "disability". A total of 37 studies were included, including 30 original articles and 7 meta-analyses. The main barriers to performing breast cancer screening for women with disabilities were environmental factors such as lack of adapted transportation means or difficult access to medical facilities and mammography. To a lesser extent, the unsupportive views of family caregivers and health care staff about screening were also barriers to screening acceptance by people with disabilities. In general, breast cancer screening is a useful public health measure that reduces the burden of treatment and breast cancer-related mortality. Screening is useful for women over 50 years of age who have a sufficiently long-life expectancy, generally estimated at more than 10 years. Educational measures are needed to reduce the barriers t...
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Source Type: research

Related Links:

Bull Cancer. 2021 Oct 14:S0007-4551(21)00368-4. doi: 10.1016/j.bulcan.2021.07.009. Online ahead of print.ABSTRACTA significant increase in breast cancer is expected in the coming decades among people with disabilities. However, their participation rate in screening programs is significantly lower than women without disabilities. Our objective was therefore to analyse the barriers to breast cancer screening in people with disabilities based on a recent review of the international literature. The articles analysed were retrieved from the PUBMED database from 2014 to 2020 using the following keywords "breast cancer"...
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Source Type: research
ConclusionThe ability of mammography and breast ultrasound to accurately measure residual tumor size following neoadjuvant chemotherapy compared to Breast MRI measurement of the residual tumor demonstrated sensitivity of 94.12 % and specificity of 83.33% with high accuracy value reaching to 91.30 %. Even that the MRI is proved to be of high accuracy in detecting residual tumor, sonomammographic imaging isa cost-effective imaging modality than the MRI with sensitivity and specificity near to that of MRI.
Source: QJM - Category: Internal Medicine Source Type: research
Conclusion: Women with CP perceive a variety of issues impacting breast health. These findings are multifaceted and suggest that improving screening rates for women with CP should address these barriers and facilitators.PMID:34235506 | PMC:PMC8243704 | DOI:10.1089/whr.2020.0115
Source: Pain Physician - Category: Anesthesiology Authors: Source Type: research
Conclusions: Pre-existing disability is associated with a higher likelihood of breast and cervical cancer diagnoses, raising the urgency of eliminating disability disparities in mammography and Pap testing. Further research will need to explore the causes of these higher cancer rates.
Source: Medical Care - Category: Health Management Tags: Original Articles Source Type: research
To quantify the impact of mammography-based screening on the quality of life, disability-adjusted life years (DALYs) averted or quality-adjusted life years (QALYs) gained can be used. We aimed to assess whether the use of DALYs averted or QALYs gained will lead to different cost-effective screening strategies.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research
By LUKE OAKDEN-RAYNER In surprising news this week, CMS (the Centres for Medicare &Medicaid Services) in the USA approved the first reimbursement for AI augmented medical care. Viz.ai have a deep learning model which identifies signs of stroke on brain CT and automatically contacts the neurointerventionalist, bypassing the first read normally performed by a general radiologist. From their press material: Viz.ai demonstrated to CMS a significant reduction in time to treatment and improved clinical outcomes in patients suffering a stroke. Viz LVO has been granted a New Technology Add on Payment of up to&nbs...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Artificial Intelligence Health Tech AI Luke Oakden-Rayner Reimbursement Source Type: blogs
This article explores the reasons women are underserved and underscreened, including cost, examination-associated pain, and inconvenience, as well as possible solutions to these and other barriers to screening mammography. The needs of special patient populations, such as women with disabilities, also are addressed, along with general measures for encouraging mammography screening participation, including patient education, reminders, and support from health care professionals. PMID: 32060093 [PubMed - in process]
Source: Radiologic Technology - Category: Radiology Authors: Tags: Radiol Technol Source Type: research
CONCLUSIONS: Long-term sustained partnerships between academic, disability, and clinical partners are needed to address the complex issues that perpetuate breast cancer screening disparities among women with disabilities. PMID: 31378736 [PubMed - in process]
Source: Progress in Community Health Partnerships - Category: International Medicine & Public Health Tags: Prog Community Health Partnersh Source Type: research
Discussion: Our results demonstrated that cancer risk was not increased in our MS population; but age and sex different distribution may partly drive cancer risk. Higher cancer risk in MS patients switching more than two DMTs should take into account in treatment decision making. Introduction Multiple Sclerosis (MS) is a severe acquired autoimmune neurodegenerative disease of the central nervous system (CNS) with extremely variable disease course, that usually affects persons in their third/four decades of life, even if late onset is described (1). Women had a prevalence/incidence rate approximately double than men (...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
The year 2018 is nearly over, and it is time for us to reveal what we believe were the most notable developments in medical technology. We considered a technology’s clinical importance, the greatness of the leap that it’s making over exis...
Source: Medgadget - Category: Medical Devices Authors: Tags: Exclusive Medicine Society Surgery Source Type: blogs
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Disability | Education | Environmental Health | Health Management | International Medicine & Public Health | Mammography | Study | Women